[Research Report] The diabetic foot ulcer market size is expected to grow from US$ 7,470.60 million in 2022 and to reach a value of US$ 12,242.77 million by 2030; it is anticipated to record a CAGR of 6.4% from 2022 to 2030.
Market Insights and Analyst View:
Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. Diabetic foot ulcer leads to full thickness skin loss on the foot due to neuropathic and/or vascular complications in patients with type 1 or type 2 diabetes mellitus. Diabetic patient who uses insulin are at a higher risk of developing a foot ulcer. Key factors driving the diabetic foot ulcer market growth include high prevalence of diabetes and related chronic wounds and surge in geriatric population. However, the high cost of wound management hinders the market growth.
Growth Drivers and Restraints:
Diabetic patients are vulnerable to wounds, and the healing process is usually longer. Depending on healing timeframe, wounds are classified as acute and chronic. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. According to the International Diabetes Federation (IDF), in 2021, there were ∼537 million adults living with diabetes worldwide. The number is anticipated to increase to 643 million by 2030 and 783 million by 2045. Blood vessels and nerves in the feet of diabetic patients are prone to damages, resulting in numbness. Due to this, diabetic patients have a higher chance of developing diabetic foot ulceration. According to a study published in 2021 in National Center for Biotechnology Information (NCBI), the risk of developing diabetic foot ulcers is between 19% and 34%. A recurrence rate of ~40% is experienced by patients within 1 year of recovery, 60% within 3 years, and 65% within 5 years. As per same study, it is reported that infection develops in 50–60% of ulcers and is the principal cause that damages diabetic feet. Thus, the demand for diabetic foot ulcer treatments is on rise globally, thereby fueling the market growth.
The diabetic foot ulcer market is further driven by surging geriatric population. Age-associated diabetes is common globally. The deficiency of insulin secretion develops with age and the insulin resistance increases due to a change in body composition and sarcopenia. According to Endocrine Society, an estimated 33% of adults aged 65 or older have diabetes. Additionally, the population is more at risk of developing diabetes-related complications. According to the Global Ageing Survey 2019, there will be a notable rise in the number of people aged 65 or above from 1 in 11 in 2019 to 1 in 6 inhabitants by 2025. As per the US Census Bureau, the number of Americans aged 65 and above is anticipated to double from 46 million in 2016 to more than 98 million by 2060, and the share of the elderly population in the global population will increase from 15% to ~24% in the same period. Moreover, the pace of aging (i.e., people aged 60 and above) by 2050 will be nearly a quarter or more in most regions across the world. Older adults are more likely to be diabetic and are further anticipated to develop diabetic foot ulcers and chronic wounds that can severely impact the quality of life. Therefore, with the growing aging population, the demand for advanced diabetic foot ulcer treatments will continue to increase in the coming years.
According to Integra LifeSciences Corporation, the cost of diabetic foot ulcers treatment has an enormous burden on the US healthcare system—ranging between US$ 9 and US$ 13 billion annually. According to the data published by the University of Huddersfield, the cost of treating health care associated infections (HCAIs), particularly surgical site infections (SSIs), has been estimated to represent £1 billion (~US$ 1.26 billion) in the UK. Further, according to Diabetes Australia, diabetes-associated limb amputation costs nearly US$ 23,555, with an additional annual expense of US$ 6,065 post surgery. Over five years, diabetes-related amputation amounts to almost US$ 50,000 for the health system, excluding social costs. The area of a wound and the complexity of procedures also determine the cost of the treatment.
The cost of diabetic foot ulcer treatment is also high in Asia Pacific countries such as India, China, and South Korea. According to a study published in 2022 by Elsevier, the cost of diabetic foot ulcer treatment is ~US$ 21,372/patient in China covering amputations, hospitalizations and medical treatments. Similarly, in India, the cost is around ~US$ 19,599/patient including antibiotics, neuropathic drugs, dressings, collagen scaffolds, growth factors, negative pressure wound therapy, and surgery. Thus, the high cost of advanced wound care treatments, despite the availability of reimbursements, is a key factor restraining the diabetic foot ulcer market growth globally.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Diabetic Foot Ulcer Market: Strategic Insights
Market Size Value in US$ 7,470.60 million in 2022 Market Size Value by US$ 12,242.77 million by 2030 Growth rate CAGR of 6.4% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Diabetic Foot Ulcer Market: Strategic Insights
| Market Size Value in | US$ 7,470.60 million in 2022 |
| Market Size Value by | US$ 12,242.77 million by 2030 |
| Growth rate | CAGR of 6.4% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Diabetic Foot Ulcer Market” is segmented on the basis of ulcer type, treatment type, infection severity, and end user. The global diabetic foot ulcer market, by treatment type, is segmented into advanced wound care dressings, biologics, and therapy device. Based on ulcer type, the market is segmented into neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers. The global diabetic foot ulcer market, by infection severity, is segmented into moderate, mild, and severe. The global diabetic foot ulcer market, by end user, is segmented into ambulatory surgical centers, hospitals, and home care.
The diabetic foot ulcer market, based on geography, is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
The global diabetic foot ulcer market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers. The neuro-ischemic ulcers segment held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2030. Neuro-ischemia predominately leads to the development of ulcers on the foot, toes, and dorsum margins, especially on pressure sites occurring among people using poorly fitting shoes. The management of such types of wounds is comparatively complex. The wound requires prompt care, appropriate footwear, offloading, dressings, and infection treatment. Neuro-ischemic ulcers are the most common diabetic foot ulcers (DFUs).
Diabetic Foot Ulcer Market, by Ulcer Type – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The global diabetic foot ulcer market, by treatment type, is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2022. The biologics segment is anticipated to register the highest CAGR during 2022–2030. The global diabetic foot ulcer market, by infection severity, is segmented into moderate, mild, and severe. The mild segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period (2022–2030). The global diabetic foot ulcer market, by end user, is segmented into ambulatory surgical centers, hospitals, and home care. The hospital segment held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2030.
Regional Analysis:
Based on geography, the global diabetic foot ulcer market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2022, North America held the largest share of the global diabetic foot ulcer market size. Asia Pacific is estimated to register the highest CAGR from 2022 to 2030.
The US diabetic foot ulcers market is primarily driven by the increasing prevalence of diabetes in the country. As per the American Podiatric Medical Association, in the US, nearly 14–24% of patients with diabetes who develop foot ulcers require an amputation. According to the Health Innovation Program, ~2 million people in America develop a diabetic foot ulcer annually. Furthermore, according to a study published in NCBI in 2022, ~5% of patients in the US with diabetes mellitus develop foot ulcers, and 1% end up with an amputation. The growing geriatric population in the region also boosts the market growth. According to the Administration on Aging (US Department of Health and Human Services) report published in 2022, there were 55.7 million people aged 65 and above in 2020 in the US. The old age group represents 17% of the population, i.e., 1 in every 6 Americans. As per estimates by the Urban Institute (Washington, DC-based think tank), the number of people aged 65 and older will double over the next 40 years, reaching 80 million in 2040 in the US. Additionally, In 2020, diabetes is regarded as among the leading chronic conditions among adults aged 65 and above. In recent years, several joint ventures, initiatives, and collaborations contributed in accelerating the diabetic foot ulcers market expansion in North America. For instance, in 2020, six research institutions in the US launched the first-ever multicenter network funded by the National Institutes of Health to study diabetic foot ulcers in the US. Additionally, the Diabetic Foot Canada program was launched in Canada to prevent diabetic foot complications. Thus, the high prevalence of diabetes and the increasing geriatric population will drive the market growth in the region.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global diabetic foot ulcer market are listed below:
- In January 2023, Convatec announced the launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a broad spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.
- In January 2023, MiMedx Group Inc announced that it had entered into an exclusive distribution agreement with GUNZE MEDICAL LIMITED (“Gunze Medical”), a subsidiary of Gunze Limited, for sales of EPIFIX in Japan. Gunze Medical is a leading distributor of products used in a wide range of wound and surgical settings, including bioabsorbable devices and materials, such as sutures and sheet products.
- In March 2022, Convatec entered the attractive wound biologics segment by acquiring Triad Life Sciences Inc. The company develops biologically derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds, and burns.
- In July 2022, Smith+Nephew announced the launch of the WOUND COMPASS Clinical Support App. It is a comprehensive digital support tool for healthcare professionals that aids wound assessment and decision-making to help reduce practice variation. The App helps improve nurse confidence when assessing and treating wounds and reassuring specialist nurses that their formulary is followed.
- In January 2020, Convatec Group Plc announced the launch of ConvaMax, the new superabsorber dressing. It is used to manage highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers, and dehisced surgical wounds.
Competitive Landscape and Key Companies:
Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Molnlycke Health Care AB, MiMedx Group Inc, URGO MEDICAL Australia Pty Ltd, Medline Industries LP, and Organogenesis Inc are among the prominent players operating in the diabetic foot ulcer market. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Ulcer Type, Treatment Type, Infection Severity, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global diabetic foot ulcer market, by end user, is segmented into ambulatory surgical centers, hospitals, and home care. The hospital segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030.
The global diabetic foot ulcer market, by treatment type, is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2022. The biologics segment is anticipated to register the highest CAGR during 2022–2030.
The global diabetic foot ulcer market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers. The neuro-ischemic ulcers segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030.
The global diabetic foot ulcer market, by infection severity, is segmented into moderate, mild, and severe. The mild segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030.
Factors such as high prevalence of diabetes and related chronic wounds and surge in geriatric population propel market growth.
The diabetic foot ulcer market has major market players, including Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Molnlycke Health Care AB, MiMedx Group Inc, URGO MEDICAL Australia Pty Ltd, Medline Industries LP, and Organogenesis Inc.
The diabetic foot ulcer market was valued at US$ 7,470.60 million in 2022.
The diabetic foot ulcer market is expected to be valued at US$ 12,242.77 million in 2030.
Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. Diabetic foot ulcer leads to full thickness skin loss on the foot due to neuropathic and/or vascular complications in patients with type 1 or type 2 diabetes mellitus. Diabetic patient who uses insulin are at a higher risk of developing a foot ulcer.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Diabetic Foot Ulcer Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Diabetic Foot Ulcer Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:
6. Diabetic Foot Ulcer Market - Global Market Analysis
6.1 Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
7. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – by Treatment Type
7.1 Overview
7.2 Global Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Ulcer Type
8.1 Overview
8.2 Global Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Infection Severity
9.1 Overview
9.2 Global Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By End User
10.1 Overview
10.2 Global Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
11. Diabetic Foot Ulcer Market - Geographical Analysis
11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1 North America Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.2 North America Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.2.1 North America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.2.2 North America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.2.3 North America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.3 North America Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.4 North America Diabetic Foot Ulcer Market, by End User
11.1.2.5 North America Diabetic Foot Ulcer Market, by Country
11.1.2.6 US
11.1.2.6.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.6.2 US Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.6.3 US Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.6.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.6.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.6.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.6.4 US Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.6.5 US Diabetic Foot Ulcer Market, by End User
11.1.2.7 Canada
11.1.2.7.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.7.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.7.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.7.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.7.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.7.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.7.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.7.5 Canada Diabetic Foot Ulcer Market, by End User
11.1.2.8 Mexico
11.1.2.8.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.8.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.8.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.8.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.8.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.8.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.8.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.8.5 Mexico Diabetic Foot Ulcer Market, by End User
11.2 Europe Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.1 Europe Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.2 Europe Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.2.1 Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.2.2 Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.2.3 Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.3 Europe Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.4 Europe Diabetic Foot Ulcer Market, by End User
11.2.2.5 Europe Diabetic Foot Ulcer Market by Country
11.2.2.6 Germany
11.2.2.6.1 Germany Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.6.2 Germany Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.6.3 Germany Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.6.3.1 Germany: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.6.3.2 Germany: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.6.3.3 Germany: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.6.4 Germany Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.6.5 Germany Diabetic Foot Ulcer Market, by End User
11.2.2.7 UK
11.2.2.7.1 UK Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.7.2 UK Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.7.3 UK Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.7.3.1 UK: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.7.3.2 UK: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.7.3.3 UK: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.7.4 UK Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.7.5 UK Diabetic Foot Ulcer Market, by End User
11.2.2.8 France
11.2.2.8.1 France Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.8.2 France Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.8.3 France Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.8.3.1 France: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.8.3.2 France: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.8.3.3 France: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.8.4 France Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.8.5 France Diabetic Foot Ulcer Market, by End User
11.2.2.9 Italy
11.2.2.9.1 Italy Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.9.2 Italy Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.9.3 Italy Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.9.3.1 Italy: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.9.3.2 Italy: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.9.3.3 Italy: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.9.4 Italy Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.9.5 Italy Diabetic Foot Ulcer Market, by End User
11.2.2.10 Spain
11.2.2.10.1 Spain Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.10.2 Spain Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.10.3 Spain Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.10.3.1 Spain: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.10.3.2 Spain: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.10.3.3 Spain: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.10.4 Spain Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.10.5 Spain Diabetic Foot Ulcer Market, by End User
11.2.2.11 Rest of Europe
11.2.2.11.1 Rest of Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.11.2 Rest of Europe Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.11.3 Rest of Europe Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.11.3.1 Rest of Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.11.3.2 Rest of Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.11.3.3 Rest of Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.11.4 Rest of Europe Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.11.5 Rest of Europe Diabetic Foot Ulcer Market, by End User
11.3 Asia Pacific Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.1 Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.2 Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.2.1 Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.2.2 Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.2.3 Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.3 Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.4 Asia Pacific Diabetic Foot Ulcer Market, by End User
11.3.2.5 Asia Pacific Diabetic Foot Ulcer Market by Country
11.3.2.6 China
11.3.2.6.1 China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.6.2 China Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.6.3 China Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.6.3.1 China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.6.3.2 China: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.6.3.3 China: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.6.4 China Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.6.5 China Diabetic Foot Ulcer Market, by End User
11.3.2.7 Japan
11.3.2.7.1 Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.7.2 Japan Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.7.3 Japan Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.7.3.1 Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.7.3.2 Japan: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.7.3.3 Japan: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.7.4 Japan Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.7.5 Japan Diabetic Foot Ulcer Market, by End User
11.3.2.8 India
11.3.2.8.1 India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.8.2 India Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.8.3 India Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.8.3.1 India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.8.3.2 India: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.8.3.3 India: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.8.4 India Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.8.5 India Diabetic Foot Ulcer Market, by End User
11.3.2.9 Australia
11.3.2.9.1 Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.9.2 Australia Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.9.3 Australia Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.9.3.1 Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.9.3.2 Australia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.9.3.3 Australia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.9.4 Australia Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.9.5 Australia Diabetic Foot Ulcer Market, by End User
11.3.2.10 South Korea
11.3.2.10.1 South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.10.2 South Korea Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.10.3 South Korea Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.10.3.1 South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.10.3.2 South Korea: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.10.3.3 South Korea: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.10.4 South Korea Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.10.5 South Korea Diabetic Foot Ulcer Market, by End User
11.3.2.11 Rest of Asia Pacific
11.3.2.11.1 Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.11.2 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.11.3 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.11.3.1 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.11.3.2 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.11.3.3 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.11.4 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.11.5 Rest of Asia Pacific Diabetic Foot Ulcer Market, by End User
11.4 Middle East & Africa Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
11.4.4 Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
11.4.4.1 Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.4.2 Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.4.3 Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.5 Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
11.4.6 Middle East & Africa Diabetic Foot Ulcer Market, by End User
11.4.6.1 Middle East & Africa Diabetic Foot Ulcer Market by Country
11.4.6.2 UAE
11.4.6.2.1 UAE Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 UAE Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.2.3 UAE Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.2.3.1 UAE: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.2.3.2 UAE: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.2.3.3 UAE: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.2.4 UAE Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.2.5 UAE Diabetic Foot Ulcer Market, by End User
11.4.6.3 Saudi Arabia
11.4.6.3.1 Saudi Arabia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 Saudi Arabia Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.3.3 Saudi Arabia Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.3.3.1 Saudi Arabia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.3.3.2 Saudi Arabia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.3.3.3 Saudi Arabia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.3.4 Saudi Arabia Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.3.5 Saudi Arabia Diabetic Foot Ulcer Market, by End User
11.4.6.4 South Africa
11.4.6.4.1 South Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.4.3 South Africa Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.4.3.1 South Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.4.3.2 South Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.4.3.3 South Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.4.4 South Africa Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.4.5 South Africa Diabetic Foot Ulcer Market, by End User
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Overview
11.4.6.5.2 Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.3 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.5.4 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.5.4.1 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.5.4.2 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.5.4.3 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.5.5 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.5.6 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by End User
11.5 South & Central America Diabetic Foot Ulcer Market, Revenue And Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.1 South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.2 South & Central America Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.2.1 South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.2.2 South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.2.3 South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.3 South & Central America Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.4 South & Central America Diabetic Foot Ulcer Market, by End User
11.5.2.5 South & Central America Diabetic Foot Ulcer Market by Country
11.5.2.6 Brazil
11.5.2.6.1 Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.6.2 Brazil Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.6.3 Brazil Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.6.3.1 Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.6.3.2 Brazil: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.6.3.3 Brazil: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.6.4 Brazil Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.6.5 Brazil Diabetic Foot Ulcer Market, by End User
11.5.2.7 Argentina
11.5.2.7.1 Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.7.2 Argentina Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.7.3 Argentina Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.7.3.1 Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.7.3.2 Argentina: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.7.3.3 Argentina: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.7.4 Argentina Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.7.5 Argentina Diabetic Foot Ulcer Market, by End User
11.5.2.8 Rest of South & Central America
11.5.2.8.1 Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.8.2 Rest of South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.8.3 Rest of South & Central America Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.8.3.1 Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.8.3.2 Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.8.3.3 Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.8.4 Rest of South & Central America Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.8.5 Rest of South & Central America Diabetic Foot Ulcer Market, by End User
12. Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Diabetic Foot Ulcer Market - Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 URGO MEDICAL Australia Pty Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medline Industries LP
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Organogenesis Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Global Diabetic Foot Ulcer Market Segmentation
Table 2. North America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 3. North America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 4. North America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 5. North America: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 6. North America: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 7. North America Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 8. North America Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 9. US Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 10. US Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 11. US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 12. US: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 13. US: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 14. US Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 15. US Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 16. Canada Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 17. Canada Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 18. Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 19. Canada: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 20. Canada: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 21. Canada Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 22. Canada Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 23. Mexico Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 24. Mexico Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 25. Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 26. Mexico: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 27. Mexico: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 28. Mexico Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 29. Mexico Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 30. Europe Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 31. Europe Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 32. Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 33. Europe: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 34. Europe: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 35. Europe Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 36. Europe Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 37. Germany Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 38. Germany Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 39. Germany: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 40. Germany: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 41. Germany: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 42. Germany Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 43. Germany Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 44. UK Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 45. UK Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 46. UK: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 47. UK: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 48. UK: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 49. UK Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 50. UK Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 51. France Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 52. France Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 53. France: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 54. France: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 55. France: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 56. France Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 57. France Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 58. Italy Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 59. Italy Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 60. Italy: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 61. Italy: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 62. Italy: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 63. Italy Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 64. Italy Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 65. Spain Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 66. Spain Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 67. Spain: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 68. Spain: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 69. Spain: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 70. Spain Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 71. Spain Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 72. Rest of Europe Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 73. Rest of Europe Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 74. Rest of Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 75. Rest of Europe: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 76. Rest of Europe: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 77. Rest of Europe Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 78. Rest of Europe Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 79. Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 80. Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 81. Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 82. Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 83. Asia Pacific: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 84. Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 85. Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 86. China Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 87. China Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 88. China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 89. China: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 90. China: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 91. China Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 92. China Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 93. Japan Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 94. Japan Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 95. Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 96. Japan: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 97. Japan: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 98. Japan Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 99. Japan Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 100. India Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 101. India Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 102. India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 103. India: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 104. India: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 105. India Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 106. India Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 107. Australia Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 108. Australia Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 109. Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 110. Australia: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 111. Australia: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 112. Australia Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 113. Australia Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 114. South Korea Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 115. South Korea Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 116. South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 117. South Korea: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 118. South Korea: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 119. South Korea Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 120. South Korea Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 121. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 122. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 123. Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 124. Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 125. Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 126. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 127. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 128. Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 129. Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 130. Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 131. Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 132. Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 133. Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 134. Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 135. UAE Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 136. UAE Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 137. UAE: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 138. UAE: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 139. UAE: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 140. UAE Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 141. UAE Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 142. Saudi Arabia Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 143. Saudi Arabia Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 144. Saudi Arabia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 145. Saudi Arabia: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 146. Saudi Arabia: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 147. Saudi Arabia Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 148. Saudi Arabia Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 149. South Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 150. South Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 151. US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 152. US: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 153. US: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 154. South Africa Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 155. South Africa Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 156. Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 157. Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 158. Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 159. Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 160. Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 161. Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 162. Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 163. South & Central America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 164. South & Central America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 165. South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 166. South & Central America: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 167. South & Central America: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 168. South & Central America Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 169. South & Central America Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 170. Brazil Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 171. Brazil Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 172. Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 173. Brazil: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 174. Brazil: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 175. Brazil Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 176. Brazil Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 177. Argentina Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 178. Argentina Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 179. Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 180. Argentina: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 181. Argentina: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 182. Argentina Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 183. Argentina Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 184. Rest of South & Central America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Ulcer Type
Table 185. Rest of South & Central America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn) – Treatment Type
Table 186. Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 187. Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device– Revenue and Forecast to 2030 (USD Million)
Table 188. Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics– Revenue and Forecast to 2030 (USD Million)
Table 189. Rest of South & Central America Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – Infection Severity
Table 190. Rest of South & Central America Diabetic Foot Ulcer Market Revenue And Forecast To 2030 (US$ Mn) – End User
Table 191. Recent Inorganic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 192. Recent Organic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 193. Glossary of Terms, Diabetic Foot Ulcer Market
List of Figures
Figure 1. Diabetic Foot Ulcer Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Diabetic Foot Ulcer Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Diabetic Foot Ulcer Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Global Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 8. Advanced Wound Care Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Alginate Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hydrofiber Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Foam Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Collagen Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Film Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Other Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Biologics: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Growth Factors: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Skin Graft: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Therapy Device: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Negative Pressure Wound Therapy: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ultrasound Therapy: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Global Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
Figure 22. Neuropathic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ischemic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Neuro-ischemic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Global Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
Figure 26. Mild: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Moderate: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Severe: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Global Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
Figure 30. Hospitals: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Ambulatory Surgical Centers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Home Care: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Diabetic Foot Ulcer Market, 2022 ($Mn)
Figure 34. North America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. North America Diabetic Foot Ulcer Market, By Key Countries, 2022 And 2030 (%)
Figure 36. US Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Canada Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. Mexico Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 39. Europe Diabetic Foot Ulcer Market, By Geography, 2022 ($Mn)
Figure 40. Europe Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 41. Europe Diabetic Foot Ulcer Market, By Key Countries, 2022 And 2030 (%)
Figure 42. Germany Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. UK Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. France Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 45. Italy Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. Spain Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 47. Rest of Europe Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 48. Diabetic Foot Ulcer Market, By Geography, 2022 ($Mn)
Figure 49. Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 50. Asia Pacific Diabetic Foot Ulcer Market, By Key Countries, 2022 And 2030 (%)
Figure 51. China Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 52. Japan Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 53. India Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 54. Australia Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 55. South Korea Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 56. Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 57. Diabetic Foot Ulcer Market, By Geography, 2022 And 2030 ($Mn)
Figure 58. Middle East & Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 59. Middle East & Africa Diabetic Foot Ulcer Market, By Key Countries, 2022 And 2030 (%)
Figure 60. UAE Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 61. Saudi Arabia Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 62. South Africa Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 63. Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Diabetic Foot Ulcer Market, By Geography, 2022 ($Mn)
Figure 65. South & Central America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 66. South & Central America Diabetic Foot Ulcer Market, By Key Countries, 2022 And 2030 (%)
Figure 67. Brazil Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 68. Argentina Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 69. Rest of South & Central America Diabetic Foot Ulcer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 70. Growth Strategies in the Global Diabetic Foot Ulcer Market
The List of Companies - Diabetic Foot Ulcer Market
- Convatec Group Plc
- 3M Co
- Coloplast AS
- Smith & Nephew Plc
- B. Braun SE
- Molnlycke Health Care AB
- MiMedx Group Inc
- URGO MEDICAL Australia Pty Ltd
- Medline Industries LP
- Organogenesis Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Diabetic Foot Ulcer Market
Sep 2023
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2023
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2023
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2023
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2023
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2023
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)